New hope for protecting transplanted kidneys
NCT ID NCT07356388
Summary
This study is testing if a drug called finerenone can safely reduce protein in the urine (proteinuria) for people who have received a kidney transplant. Researchers will compare it to another drug, dapagliflozin, in 54 adult transplant recipients. The goal is to find better ways to protect the transplanted kidney from long-term damage.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANTATION RECIPIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Changhai Hospital
Shanghai, Shanghai Municipality, 200082, China
Conditions
Explore the condition pages connected to this study.